Castle Biosciences, Inc.
CSTLNASDAQHealthcare● Active
$20.12
$-0.89(-4.24%)
Market Cap$610238634
P/E Ratio—
52W High$44.28
52W Low$14.59
Castle Biosciences, Inc.（CSTL）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CSTL · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.02B) | $0.02B | ($0.06B) | ($0.07B) | ($0.03B) |
| Depreciation & Amort. | $0.04B | $0.02B | $0.01B | $0.01B | $0.00B |
| Stock-Based Comp. | $0.05B | $0.05B | $0.05B | $0.04B | $0.02B |
| Change in Working Capital | $0.01B | ($0.01B) | ($0.01B) | ($0.00B) | ($0.00B) |
| Net Cash from Operations | $0.06B | $0.06B | ($0.01B) | ($0.04B) | ($0.02B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.04B) | ($0.03B) | ($0.01B) | ($0.01B) | ($0.00B) |
| Purchases of Investments | ($0.19B) | ($0.21B) | ($0.19B) | ($0.13B) | $0.00B |
| Sales of Investments | $0.19B | $0.18B | $0.19B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.06B) | ($0.05B) | ($0.02B) | ($0.17B) | ($0.07B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | ($0.00B) | $0.01B | ($0.00B) | ($0.00B) | ($0.00B) |
| Net Cash from Financing | ($0.01B) | $0.01B | ($0.00B) | $0.00B | $0.01B |
| Free Cash Flow | |||||
| Free Cash Flow | $0.03B | $0.04B | ($0.02B) | ($0.05B) | ($0.02B) |
| FCF Margin %(computed) | 8.23% | 11.00% | -8.76% | -34.51% | -23.88% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Castle Biosciences, Inc.
关于Castle Biosciences, Inc.（CSTL）现金流量表
Castle Biosciences, Inc. 2025财年经营活动现金流$0.06B，自由现金流$0.03B（FCF利润率8.23%），资本支出($0.04B)。
常见问题
CSTL · 4 问Castle Biosciences, Inc. 2025财年自由现金流$0.03B，同比down22.5%。
CSTL free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10